Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06249997Phase 3Unknown

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

Role: collaborator

NCT01546012Not ApplicableWithdrawn

Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

Role: collaborator

NCT01552174Completed

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Role: collaborator

All 3 trials loaded